Abstract
In a prospective, randomized, controlled study of 64 patients after bilateral subtotal thyroidectomy, a high dosage of 1.0 mg L-thyroxine taken once a week was compared to the usual intake of 0.1 mg L-thyroxine daily for prevention of recurrent goiter. During a follow-up study for 52 weeks, the effectiveness and acceptability of an intermittent high dosage was assessed clinically and also by measuring basal TSH, stimulated TSH, iT4, and iT3. In both groups, postoperative elevated TSH levels could be reduced to subnormal levels by L-thyroxine intake. iT3 and iT4 levels remained in the normal range after either daily or intermittent therapy. The weekly high dosage of 1.0 mg L-thyroxine has proved to be at least as effective as the usual therapy with no apparent disadvantage.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Järnerot, G., Karlberg, B.E.: Experience with a thyroid suppression test using a large oral dose of thyroxine. Sven. Läk.-Tidn.70:381, 1973
Sekadde, C.B., Slaunwhite, W.R., Aceto, T., Murray, K.: Administration of thyroxine once a week. J. Clin. Endocrinol. Metab.39:759, 1974
Bernstein, R.S., Robbins, J.: Intermittent therapy with L-thyroxine. N. Engl. J. Med.281:1444, 1969
Gemensenjäger, E., Staub, J.J., Gerard, J., Heitz, P.: Die hypophysäre TSH-Reserve in einem chirurgischen Krankengut von biander Struma and Rezidivstruma. Schweiz. Med. Wochenschr.106:854, 1976
Hedley, A.J., Amos, J., Hall, R., Michie, W., Crooks, J.: Serum-thyrotropin levels after subtotal thyroidectomy for Grave's Disease. Lancet1:455, 1971
Braverman, L.E., Ingbar, S.H., Sterling, K.: Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J. Clin. Invest.49:855, 1970
Pittmann, C.S., Chambers, J.B., Read, V.H.: The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man. J. Clin. Invest.50:1187, 1971
Odell, W.D., Utiger, R.D., Wilber, J.F., Condliffe, P.G.: Estimation of the secretion rate of thyrotropin in man. J. Clin. Invest.46:953, 1967
Braverman, L.E., Vagenakis, A., Downs, P., Forster, A.E., Sterling, K., Inbar, S.H.: Effects of replacement doses of sodium-L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J. Clin. Invest.52:1010, 1973
Hays, M.T.: Absorption of oral thyroxine in man. J. Clin. Endocrinol.28:749, 1968
Wenzel, K.W., Meinhold, H.: Evidence of lower toxicity during thyroxine suppression after a single 3 mg L-thyroxine dose: Comparison to the classical L-triiodothyronine test for thyroid suppressibility. J. Clin. Endocrinol. Metab.38:902, 1974
Hoff, H.G., Hackenberg, K., Reinwein, D.: Auswirkungen einer einzeitigen hohen Thyroxindosis auf die Hypophysen-Schilddrüsenachse bei euthyreoter und hypothyreoter Stoffwechsellage. Verh. Dtsch. Ges. Inn. Med.83:1358, 1977
Zechmann, B., Fill, H., Riccabona, G., Obendorf, L.: Resorption und Pharmakokinetik großer Dosen von L-Thyroxin beim Menschen. Wien. Klin. Wochenschr.87:751, 1975
Ridgway, E.C., McCammon, J.A., Benotti, J., Malcof, F.: Acute metabolism responses in myxedema to large dose of intravenous L-thyroxine. Ann. Int. Med.77:549, 1972
Doepp, M., Grebe, S.F., Sutedja, B.: Eine Methode zur besseren Dosierung von L-Thyroxin in der Suppressionstherapie in der Schilddrüse. Therapiewoche28:1000, 1978
Sterling, K., Bellabarba, D., Newman, E.S., Brenner, M.A.: Determination of triiodothyronine concentration in human serum. J. Clin. Invest.48:1150 1969
Read, D.G., Hays, M.T., Hershman, J.M.: Absorption of oral thyroxine in hypothyroid and normal man. J. Clin. Endocrinol. Metab.30:798, 1970
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goretzki, P., Roeher, H.D. & Horeyseck, G. Prophylaxis of recurrent goiter by high-dose L-thyroxine. World J. Surg. 5, 855–857 (1981). https://doi.org/10.1007/BF01657975
Issue Date:
DOI: https://doi.org/10.1007/BF01657975